TOP TIERMARKET NEWSWIRE
SEC Form 4 history

VERTEX PHARMACEUTICA (VRTX) insider trades

VERTEX PHARMACEUTICA (VRTX) insider trading activity (SEC Form 4). Over the trailing 90 days, VRTX insiders filed 0 purchases totalling $0 and 12 sales totalling $10.4M — net SELLING of $10.4M. Most recent filing: Jul 7, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
12
$10.4M
Net (90d)
-$10.4M
net selling
Most recent
Jul 7, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 7, 2026Tatsis OuraniaEVP, Chief Reg., Quality OfficS Sale—$524.99$787Kfiling
Jul 7, 2026McKechnie DuncanEVP, Chief Commercial OfficerS Sale—$519.00$800Kfiling
Jul 6, 2026Liu JoyEVP, GCS Sale—$502.71$416Kfiling
Jun 30, 2026Bozic CarmenEVP, CMOS Sale—$482.50$288Kfiling
Jun 23, 2026Bozic CarmenEVP, CMOS Sale—$462.17$471Kfiling
Jun 17, 2026Bozic CarmenEVP, CMOS Sale—$450.00$1.8Mfiling
Jun 9, 2026Bozic CarmenEVP, CMOS Sale—$450.00$785Kfiling
Jun 3, 2026Liu JoyEVP, GCS Sale—$439.91$364Kfiling
Jun 2, 2026Bozic CarmenEVP, CMOS Sale—$450.00$888Kfiling
May 19, 2026Bozic CarmenEVP, CMOS Sale—$453.45$614Kfiling
May 19, 2026Bunnage Mark E.EVP, Chief Scientific OfficerS Sale—$453.45$15Kfiling
May 14, 2026Bozic CarmenEVP, CMOS Sale—$450.00$3.1Mfiling